lct.cOm.au offers information on living cell therapy for treating diabetes
About lct.cOm.au
LCT is a New Zealand based biotechnology company focused on developing living cell products for the treatment of diabetes, neurological disease and haemophilia. We have collaborations in Melbourne, Sydney, Auckland, Germany, Italy, Russia and the US. LCT is internationally recognised for its research and development of therapies in disease areas that typically have no cure or poor treatment options. Our most advanced therapy, DIABECELL® for Type 1 diabetes is in Phase IIa trials.
